Ontario Institute for Cancer Research: Cancer Therapeutics Innovation Pipeline Program
Research Admin Offices:
- HRS
Funding Type:
GrantOpportunity Type:
- Grant
Value:
Up to $150,000 over one year for early validation and early accelerator projects.
Up to $500,000 over one year for late accelerator projects.
Disciplines:
- Health Sciences
Sponsors:
Deadlines:
Internal Deadline:
April 29, 2025Sponsor Deadline:
July 31, 2025Additional Dates:
- Information Webinar - April 23, 2025
- HRS LOI Due Date - April 29, 2025
- Sponsor LOI Due Date - May 13, 2025
- Sponsor Application Due Date (by invitation) - July 31, 2025
Description:
This opportunity supports projects that aim to provide increasing evidence of target validation and disease association using data from knowledge bases, functional assays, and drug screening in relevant in vitro and in vivo models of the cancer type of interest.
Resources:
Contact:
If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.